Search Results
Drs. Munshi, Bahlis, & Ghobrial discuss #MultipleMyeloma at #ASH22 - http://bit.ly/3FH1LxK
BCMA Therapy & the Road to Remission in Myeloma
Efficacy and Safety of Elranatamab in Pts with Relapsed/Refractory Multiple Myeloma: MagnetisMM-3
Evaluation of Sustained MRD Negativity w/ Daratumumab-Combination Regimens in Relapsed Refractory MM
Exploring the Use of Liquid Biopsies in Smoldering Multiple Myeloma
Addressing Disparities in Multiple Myeloma and the Path to Health Equity
2016 National Conference: Dr Venner - MCRN Database - Optimizing Patient Outcomes
Current and Future Directions for Novel Therapy for Multiple Myeloma: Paul G. Richardson, MD
Relapsed myeloma: How to make sense of the many options available
ASH 2022: Talquetamab in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Phase 1/2 Re...
Dr. Paola Neri | ASH 2017 | Genomics of the pathogenesis and progression of MM: Session highlights
One size fits all for induction therapy in myeloma: What you need to know
